Status:
COMPLETED
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Dartmouth-Hitchcock Medical Center
Johns Hopkins University
Conditions:
Age-related Macular Degeneration
Depression
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
This randomized, controlled clinical trial, the Low Vision Depression Prevention TriAL (VITAL), will test the efficacy of collaborative low vision rehabilitation (LVR) to prevent depressive disorders ...
Detailed Description
Age-related macular degeneration (AMD) is the leading cause of blindness in older persons in the U.S. and affects more than 10 million people. One third of patients with AMD become clinically depresse...
Eligibility Criteria
Inclusion
- Age at least 65 years old
- Bilateral AMD
- Subthreshold depressive symptoms
- At least 1 vision goal that is important yet difficult to carry out
Exclusion
- Uncontrolled glaucoma, diabetic retinopathy, corneal dystrophy, or cataracts for which surgery within 6 months is likely will be exclusionary conditions
- Current diagnosis of depression
- Cognitive impairment
- Life-threatening illness or any other health conditions that interferes with study activities.
- Patients who have received low vision rehabilitation or home-based OT in the preceding 12 months will be excluded.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT00769015
Start Date
June 1 2009
End Date
June 1 2014
Last Update
November 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107